In summary, our study presented evidence that IL-21 rs6822844 polymorphism was associated with significantly decreased RA risk and that the RF autoantibody may be considered as a biomarker for the detection of RA susceptibility. The gene discussed is IL21; the disease is rheumatoid arthritis.